Sign In to Request a Protocol
Sign In to Request a Protocol

SS-31 (50 mg Vial) Vitality Labs Protocol

  • Table of Contents
Authorship and review
  • Written by
  • Published
  • Evidence basis
  • Medical review
  • Corrections

SS-31 Overview

SS-31 is presented for general research and educational reference. This page provides an overview of SS-31, including general product information and research background. This information is intended for educational and informational purposes only.
  • Product Information: SS-31 is supplied as a lyophilized research peptide for laboratory and educational applications.
  • Research Focus: SS-31 has been widely discussed in scientific literature for its role in mitochondrial research and cellular function.
  • Storage: Store according to the instructions provided on the product label or packaging to help maintain product quality.
SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane, supporting mitochondrial function in research settings. It has been widely investigated in preclinical studies involving cellular energy production, oxidative stress, and mitochondrial health. This educational overview is intended to provide general research information and should not be considered medical advice, treatment guidance, or usage instruction.
  • Product Information Guide
Educational guide for product information and research referencereference

Standard / General Information

Route: Subcutaneous injection | Frequency: Once daily

TimeframeProtocol ValueAssessment UnitsApplication Volume
Weeks 1–25 mg30 units0.30 Vol
Weeks 3–810 mg60 units0.60 Vol

For ≤10-unit (≤0.10 mL) administrations during Weeks 1–4, consider using 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  • 1 . Draw 3.0 mL Review the product label before use.
  • 2 . Keep the product in its original container until needed..
  • 3 . Handle the product carefully during laboratory use.
  • 4 . Store according to the instructions provided on the product label.

Additional Research Information

Some research references discuss additional observations during different stages of laboratory studies. This section provides general educational information and should be used as a research reference only.
Route: Laboratory research reference | Category: Educational information for SS-31 research
TimelineBaseline ValueTarget Unit MeasurementVolume Equivalent (per application)
Loading (Weeks 1–4)1,500 mcg (1.5 mg)~750 mcg each22.5 units (0.225 mL)
Maintenance (Weeks 5–8)1,000 mcg (1.0 mg)~500 mcg each15 units (0.15 mL)

Note: For additional product information, please contact us on Telegram.

Important:This guide is provided for educational and research purposes only. It is not medical advice, treatment guidance, or usage instruction. Not for human consumption.
  • Supplies Needed
  • SS-31 (50 mg Vial)):
  • 4 weeks (28 doses at ~0.67–1.0 mg/day): 2 vials
  • 6 weeks (42 doses): 3 vials
  • 8 weeks (56 doses): 3–4 vials
  • Insulin Syringes (U-100):
  • Per week: 7 syringes (1/day)
  • 4 weeks: 28 syringes
  • 6 weeks: 42 syringes
  • 8 weeks: 56 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • 4 weeks (2 vials): 6 mL → 1 × 10 mL bottle
  • 6 weeks (3 vials): 9 mL → 1 × 10 mL bottle
  • 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 4 weeks: 56 swabs → recommend 1 × 100-count box
  • 6 weeks: 84 swabs → recommend 1 × 100-count box
  • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
  • Protocol Overview
Concise summary of the general research overview.
  • Goal: Support mitochondrial function, enhance ATP production, and reduce oxidative stress in tissues with high metabolic demand.
  • Research Focus: General research information based on published scientific literature.
  • Product Information: This product is intended for laboratory research and educational purposes only.
  • Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL total) for accurate unit measurements.
  • Storage: Store according to the instructions provided on the product label or packaging.
  • Research Information
General research overview.
  • Research Focus: SS-31 has been widely studied in laboratory research involving mitochondrial function and cellular health.
  • Product Information:This product is intended for laboratory research and educational purposes only.
  • Research Status: Ongoing scientific research continues to explore the potential applications of SS-31 in various areas of study.
  • Product Guidance: Please refer to the product label or packaging for general product information and handling recommendations.
  • Additional Information: For the latest product information or availability, please contact us on Telegram.
  • Storage Instructions
Proper storage helps maintain product quality and stability.
  • Storage: Store according to the instructions provided on the product label or packaging.
  • Handling: Keep the product in a cool, dry place and protect it from excessive heat, moisture, and direct sunlight.
  • Always follow the storage and handling recommendations provided with the product packaging.
  • Important Notes
Practical considerations for product handling and research reference.
  • Follow standard laboratory handling practices when working with the product.
  • Refer to the product label or packaging for general handling recommendations.
  • Use the product only for laboratory research and educational purposes.
  • Review product information before laboratory use to ensure proper handling.
  • This product is intended for research purposes only and is not approved for human consumption.
  • How This Works
How This Works SS-31 is a synthetic pentadecapeptide (15 amino acids) originally isolated from human gastric juice. Preclinical research indicates it exerts cytoprotective effects across multiple organ systems, promotes angiogenesis, modulates nitric oxide pathways, and interacts with growth-factor systems involved in tissue repair. TB-500 (Thymosin β4) is a naturally occurring peptide that regulates actin polymerization, promotes cell migration, reduces inflammation, and supports wound healing and tissue regeneration. The combination is hypothesized to provide complementary mechanisms for accelerated musculoskeletal and soft-tissue recovery.
  • Potential Benefits & Side Effects
Observations from preclinical and early clinical literature.
  • Tissue Repair: Both peptides have been investigated in preclinical research for their potential roles in wound healing, tendon repair, and inflammatory response.
  • Gastrointestinal Support: SS-31 has been studied for its gastroprotective properties in preclinical research.
  • Safety Profile: Preclinical and early clinical research has generally reported favorable tolerability; however, additional research is needed to better understand long-term outcomes.
  • Possible Side Effects: Research findings may vary between studies. This information is provided for educational and research purposes only and should not be considered medical advice or treatment guidance.
  • Lifestyle Factors
Complementary strategies to support overall wellness.
  • Prioritize adequate protein intake to support tissue synthesis and repair.
  • Maintain an active lifestyle with appropriate physical activity based on individual needs.
  • Ensure quality sleep and effective stress management to support overall recovery and well-being.
  • Stay hydrated and maintain a balanced intake of essential nutrients, including vitamins and minerals, to support connective tissue health.
  • Injection Technique
General product handling information for laboratory research.
  • Product Preparation: Review the product label and packaging before handling. Ensure all materials are clean and suitable for laboratory use.
  • Product Handling: Handle the product carefully using standard laboratory practices. Follow all instructions provided with the product.
  • Research Environment: Use the product in an appropriate laboratory setting and maintain a clean working environment throughout the process.
  • General Guidance: Refer to the product documentation for additional handling recommendations and product information.
  • Product Care: Handle the product carefully to help maintain its quality and integrity during laboratory use.
  • After Handling: Return the product to its recommended storage conditions immediately after use.
  • Disposal: Dispose of packaging and laboratory materials according to your local laboratory guidelines and regulations.
  • Recommended Source
General information about SS-31 (50 mg Vials).

Why Choose Vitality Labs?

  • High-quality research peptides produced in accordance with established quality standards.
  • Products are accompanied by comprehensive documentation and quality information where applicable.
  • Carefully packaged to help maintain product quality during storage and handling.
  • Dedicated support is available through our Telegram channel for product information and assistance.
Contact on Telegram
  • Important Note
This content is provided for educational and research purposes only and does not constitute medical advice, diagnosis, or treatment. SS-31 is intended for laboratory research and educational use. Research into its potential applications is ongoing. Always consult with a qualified healthcare professional regarding any medical questions or health-related decisions.
  • References

Explore related research dosage protocols and background reading for BPC-157 + TB-500.

PubMed

— Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
More Info

Current Pharmaceutical Design (PubMed)

— Stable gastric pentadecapeptide SS-31 (50 mg Vial): novel therapy in gastrointestinal tract
More Info

PMC

— Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 for regenerative therapies
More Info

Annals of the New York Academy of Sciences (PubMed)

— Thymosin beta 4 and wound healing: new ideas
More Info

PMC

— Emerging use of SS-31 (50 mg Vial) in orthopaedic sports medicine: a systematic review
More Info

Johns Hopkins Arthritis Center

— How to give a subcutaneous injection
More Info

PMC

— Subcutaneous drug delivery review: pharmacologic considerations
More Info

ASIPP / Alternative Therapies in Health and Medicine

— Intra-articular injection of SS-31 (50 mg Vial)for multiple types of knee pain
More Info

A4M

— Thymosin Beta-4 professional monograph
More Info

PubMed

— Detection of thymosin beta-4 and related peptides in sport drug testing
More Info

Journal of Physiology and Pharmacology (PubMed)

— SS-31 (50 mg Vial)activity at very low doses without toxicity in animal studies
More Info

Expert Opinion on Biological Therapy (PubMed)

— Thymosin beta-4 and its role in wound healing
More Info

CDC

— Vaccine administration: subcutaneous route (angle/site; no aspiration)
More Info

NCBI Bookshelf

— Best practices for injection (asepsis, preparation, and administration)
More Info

Contact on Telegram

SS-31 (50 mg Vial) + TB-500 (10 mg blend) product page (quality and batch documentation)
More Info